Bristol-Myers Squibb has signed an agreement worth $475 million to develop a new form of cancer immunotherapy drug with US biotech Dragonfly Therapeutics. BMS is best known as an early pioneer of ...
KULR Technology Group, Inc. (NYSE American: KULR) (the "Company" or "KULR"), a Bitcoin+ Treasury company that builds a portfolio of frontier technology businesses ranging from high-performance energy ...
Bristol-Myers Squibb has upgraded a long-running alliance with Prothena in Alzheimer’s disease, taking an option on a tau protein-targeting antibody in early-stage clinical development. The deal – ...
TipRanks on MSN
KULR Technology launches next-gen Battery Management System
Group announced the launch of its next generation KULR-developed Battery Management System, an advanced solution engineered ...
The drugmaker has launched an international Phase I trial, dubbed Breakfree-2, in seven countries to test the autologous therapy.
Deploy this example to create a 3D object reconstruction workflow that transforms stereo video input into high-quality 3D assets using state-of-the-art computer vision and neural rendering techniques.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback